VALEANT PHARMACEUTICALS INTL INC T.VRX

Lot of negative articles

[justacomment]

Not a conspiracy theorist but seems that every story on VRX has a negative spin to it.  Even if the drug review is successful, there seems to be a lot of articles lined up on bashing the revenue stream.

It takes a lot of effort to turn sentiment and it don'ts seem to be going that way for VRX.

[knowsnothing]

Those with negative articles have or related to whom have ahort positions... let's see what happens in the next few days

[richc3]

Tomorrow will certainly be a big day for us, but some of it may come down to timing. Relistor is expected to be approved and should give us a good shot in the arm, but the FDA meeting to discuss brodalumab, which is also on Tuesday, will likely lean towards the more negative side of things. So a big question is, what time will the results be released on each of these tomorrow and how will the

[acelliste]

Even If brodalumab is negative, an approval of relistor oral should be huge positve for the stock.  For comparison, if the Walgreen conference call comment raised VRX a few dollars imagine how high the share price will be with a new drug approval. But then again the market is nuts.